Literature DB >> 31219274

Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resin.

Kristine Rømer Thomsen1, Christian Lindholst2, Birgitte Thylstrup1, Sinikka Kvamme1, Lotte Ask Reitzel2, Martin Worm-Leonhard2, Amir Englund3, Tom P Freeman4, Morten Hesse1.   

Abstract

Globally, recent studies report increases in Δ-9-tetrahydrocannabinol (THC) concentration in seized samples of cannabis for human consumption. This is important, because use of cannabis with a high concentration of THC has been linked to a number of adverse health outcomes. The objective of this study was to assess recent changes in the composition of seized cannabis resin in Denmark by (a) examining THC concentration in samples from Danish forensic laboratories from 2000 to 2017 (N = 430) and (b) examining cannabidiol (CBD) concentration and the THC:CBD concentration ratio in samples from the forensic laboratory in Western Denmark from 2008 to 2017 (N = 147). Cannabis resin samples were analyzed using a gas chromatographic analysis with flame ionization detection quantifying the total THC and CBD concentration. Results showed that the THC concentration increased 3-fold from 2000 (mean: 8.3%) to 2017 (mean: 25.3%). Significant increases occurred in all areas of Denmark. After 2011, we found a dramatic increase in cannabis resin samples with high THC concentration and the near disappearance of cannabis resin samples with medium- and low THC concentration. Furthermore, the THC:CBD concentration ratio increased significantly from 1.4 in 2008 to 4.4 in 2017. Whereas THC concentration increased, CBD concentration remained stable at ∼6%. In conclusion, the THC concentration of cannabis resin, and THC:CBD concentration ratio, have increased dramatically in Denmark, potentially leading to higher risk of harm to users. Policymakers, treatment professionals, and educators should be aware of this change. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Year:  2019        PMID: 31219274     DOI: 10.1037/pha0000303

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  7 in total

Review 1.  Analytical Techniques for Phytocannabinoid Profiling of Cannabis and Cannabis-Based Products-A Comprehensive Review.

Authors:  Gjoshe Stefkov; Ivana Cvetkovikj Karanfilova; Veronika Stoilkovska Gjorgievska; Ana Trajkovska; Nikola Geskovski; Marija Karapandzova; Svetlana Kulevanova
Journal:  Molecules       Date:  2022-02-01       Impact factor: 4.411

2.  Cannabis use and associated factors among 15-16-year-old adolescents in Estonia 2003-2019: Results from cross-sectional ESPAD surveys.

Authors:  Merili Tamson; Sigrid Vorobjov; Diana Sokurova; Kersti Pärna
Journal:  Nordisk Alkohol Nark       Date:  2021-04-08

3.  Beyond the high: Mapping patterns of use and motives for use of cannabis as medicine.

Authors:  Sinikka L Kvamme; Michael M Pedersen; Sagi Alagem-Iversen; Birgitte Thylstrup
Journal:  Nordisk Alkohol Nark       Date:  2021-02-25

4.  Overview: Exploring the onto-politics of cannabis.

Authors:  Thomas Friis Søgaard; Tuulia Lerkkanen
Journal:  Nordisk Alkohol Nark       Date:  2021-08-10

5.  Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis.

Authors:  Tabea Schoeler; Jason Ferris; Adam R Winstock
Journal:  Transl Psychiatry       Date:  2022-09-06       Impact factor: 7.989

6.  Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.

Authors:  Sinikka L Kvamme; Michael M Pedersen; Kristine Rømer Thomsen; Birgitte Thylstrup
Journal:  Harm Reduct J       Date:  2021-07-10

7.  Increasing potency and price of cannabis in Europe, 2006-16.

Authors:  Tom P Freeman; Teodora Groshkova; Andrew Cunningham; Roumen Sedefov; Paul Griffiths; Michael T Lynskey
Journal:  Addiction       Date:  2019-01-16       Impact factor: 6.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.